IL96402A0 - Peptides - Google Patents

Peptides

Info

Publication number
IL96402A0
IL96402A0 IL96402A IL9640290A IL96402A0 IL 96402 A0 IL96402 A0 IL 96402A0 IL 96402 A IL96402 A IL 96402A IL 9640290 A IL9640290 A IL 9640290A IL 96402 A0 IL96402 A0 IL 96402A0
Authority
IL
Israel
Prior art keywords
grp
bombesin
derivatives
gastric
thiomethylene
Prior art date
Application number
IL96402A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL96402A0 publication Critical patent/IL96402A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57572—Gastrin releasing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL96402A 1989-11-22 1990-11-19 Peptides IL96402A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44054789A 1989-11-22 1989-11-22
US60383090A 1990-10-31 1990-10-31

Publications (1)

Publication Number Publication Date
IL96402A0 true IL96402A0 (en) 1991-08-16

Family

ID=27032451

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96402A IL96402A0 (en) 1989-11-22 1990-11-19 Peptides

Country Status (16)

Country Link
EP (1) EP0434979B1 (no)
JP (1) JP2927936B2 (no)
KR (1) KR910009730A (no)
CN (1) CN1051914A (no)
AT (1) ATE132501T1 (no)
AU (1) AU638775B2 (no)
CA (1) CA2030212A1 (no)
DE (1) DE69024626T2 (no)
ES (1) ES2084635T3 (no)
FI (1) FI905741A (no)
HU (1) HUT55798A (no)
IE (1) IE904211A1 (no)
IL (1) IL96402A0 (no)
NO (1) NO905038L (no)
NZ (1) NZ236114A (no)
PT (1) PT95953A (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5834433A (en) * 1990-07-26 1998-11-10 Merrell Pharmaceuticals Inc. Compounds and pharmaceutical uses of peptides of bombesin and GRP
CA2109322C (en) * 1991-05-23 2002-11-05 Judson V. Edwards Bombesin analogs
HUT71585A (en) * 1992-02-07 1995-12-28 Merrell Dow Pharma Process for producing bombesin phenylalanine analogue peptides
US5410018A (en) * 1994-02-25 1995-04-25 Oregon Regional Primate Research Center Bombesin-related peptides
TR200100916T2 (no) * 1998-07-14 2002-06-21 Corixa@@Corporation
EP2161037A3 (en) 2003-04-22 2010-05-26 Ipsen Pharma Camptothecin-Somatostatin conjugates
CN100372869C (zh) * 2006-04-18 2008-03-05 河北师范大学 棕点湍蛙抗微生物多肽及其在制药中的应用
CN101445554B (zh) * 2008-12-26 2012-06-27 辽宁师范大学 林蛙抗癌肽及其制备方法
CN110133295A (zh) * 2012-03-18 2019-08-16 株式会社资生堂 疾病样品分析装置、分析系统及分析方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド

Also Published As

Publication number Publication date
HUT55798A (en) 1991-06-28
JP2927936B2 (ja) 1999-07-28
FI905741A (fi) 1991-05-23
NZ236114A (en) 1993-04-28
PT95953A (pt) 1991-09-13
CA2030212A1 (en) 1991-05-23
FI905741A0 (fi) 1990-11-21
DE69024626T2 (de) 1996-05-15
JPH03261800A (ja) 1991-11-21
AU6679390A (en) 1991-05-30
EP0434979B1 (en) 1996-01-03
ES2084635T3 (es) 1996-05-16
HU907234D0 (en) 1991-05-28
DE69024626D1 (de) 1996-02-15
AU638775B2 (en) 1993-07-08
CN1051914A (zh) 1991-06-05
NO905038L (no) 1991-05-23
IE904211A1 (en) 1991-05-22
ATE132501T1 (de) 1996-01-15
NO905038D0 (no) 1990-11-21
KR910009730A (ko) 1991-06-28
EP0434979A1 (en) 1991-07-03

Similar Documents

Publication Publication Date Title
IL96402A0 (en) Peptides
DE69020794D1 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
AU6223190A (en) Novel peptidase and isomerase inhibitors
EP0403158A3 (en) Imidazolyl-alkenoic acids
DE69021386D1 (de) Verfahren und zusammensetzungen zur heilung von geschwüren.
EP0825996A4 (en) FACTOR-1 (FHF-1) HOMOLOGATED FIBROBLAST GROWTH FACTOR AND METHODS OF USE
ES2063769T3 (es) Clon de adn del inhibidor del factor tisular humano.
AU641789B2 (en) Peptides
GR3025003T3 (en) Bombesin analogs
AU6092490A (en) Peptides having bradykinin antagonist action
DE3878231D1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
EP0296581A3 (en) Amino acid 1,2-diketo derivatives as renin inhibitors
ZA878249B (en) Method and therapeutic compositions for the treatment of bleeding disorders
EP0312157A3 (en) Tetrapeptide renin inhibitors having a novel c-terminal amino acid
EP0102026A3 (en) Thiazole derivatives
EP0832109A4 (en) FIBROPLAST GROWTH FACTOR APPROVED FACTOR-2 AND METHODS OF USE
MY103208A (en) Cyanoguanidine derivative and process for preparation thereof
DE3665462D1 (en) Pharmacologically active peptides
JPS5775960A (en) Purified polypeptide
EP0266006A3 (en) Novel hypotensive diuretic peptides